Understand the source comparison
The Structural Chemistry Behind Spadin vs PE-22-28
Spadin was originally isolated as a 17-amino-acid peptide fragment from sortilin, a neuronal sorting receptor implicated in depression pathways. The sequence (GMEQDAGTPCLDPCL) contains two cysteine residues forming a critical disulfide bridge that stabilises t
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Spadin was originally isolated as a 17-amino-acid peptide fragment from sortilin, a neuronal sorting receptor implicated in depression pathways. The sequence (GMEQDAGTPCLDPCL) contains two cysteine residues forming a critical disulfide bridge that stabilises the bioactive conformation required for TREK-1 binding. PE-22-28 represents residues 22–28 of the parent protein propeptide sequence. The minimal fragment retaining TREK-1 inhibitory activity without the disulfide constraint.
- The structural simplification of PE-22-28 eliminates two major stability liabilities: oxidation-prone cysteine residues and the conformational flexibility of the longer chain. In comparative stability assays, PE-22-28 maintained 92% purity after 14 days at room temperature in phosphate-buffered saline, while full-length Spadin degraded to 68% purity under identical conditions. This difference compounds in research timelines. A 12-week behavioural study using Spadin requires cold-chain storage and weekly reconstitution, while PE-22-28 tolerates ambient storage in lyophilised form.
- Spadin analogs modify the original sequence through N-terminal acetylation, C-terminal amidation, or substitution of L-amino acids with D-enantiomers to resist peptidase cleavage. These modifications alter half-life and tissue distribution. Acetylated Spadin demonstrates a plasma half-life of approximately 4.2 hours versus 1.8 hours for unmodified Spadin, according to pharmacokinetic data from rodent models. PE-22-28's half-life sits at approximately 2.5 hours. Longer than native Spadin but shorter than heavily modified analogs.